好爽又高潮了毛片免费下载,国产97在线 | 亚洲,亚洲一区二区三区AV无码,特级AAAAAAAAA毛片免费视频

行業產品

  • 行業產品

華瑞科研網-ELISA試劑盒


當前位置:華瑞科研網-ELISA試劑盒>技術文章>鈣粘蛋白相關的神經受體1抗體,Anti-CNR1抗體
技術文章

鈣粘蛋白相關的神經受體1抗體,Anti-CNR1抗體

閱讀:636發布時間:2015-1-13

鈣粘蛋白相關的神經受體1抗體,Anti-CNR1抗體Background: Cannabinoid Receptor 1 is one of two main cannabinoid receptors which are G-protein-coupled receptors inhibiting adenylate cyclase activity. The CB(1) receptor is densely distributed in areas of the brain related to motor control, cognition, emotional responses, motivated behaviour and homeostasis. Cannabinoid receptors have a complex molecular architecture that allows a single receptor to recognize multiple classes of compounds and produce an array of distinct downstream effects.
Recent pharmacological advances have led to the synthesis of cannabinoid receptor agonists and antagonists. This has helped in the development of new strategies for the treatment of pain, obesity, neurological diseases including multiple sclerosis, emotional disturbances such as anxiety and other psychiatric disorders including drug and alcohol addiction

鈣粘蛋白相關的神經受體1抗體,Anti-CNR1抗體別    名 Cannabinoid Receptor I; CANN 6; CANN6; Cannabinoid receptor I brain; CB 1; CB R; CB1; CB1A; CB1K5; CbR; Central cannabinoid receptor; Central cannabinoid receptor isoform a; Central cannabinoid receptor isoform b; CNR 1; CNR; CNR-1; CNR1_HUMAN

鈣粘蛋白相關的神經受體1抗體,Anti-CNR1抗體相關產品:

Anti-CCRK(Cell cycle related kinase)  細胞周期相關激酶抗體
Anti-CD10/CALLA (Neutral Endopeptidase)  CD10抗體
Anti-CD105/Endoglin/TGF-β receptor  CD105/轉化生長因子β受體抗體
Anti-CD117/c-kit/SCFR  干細胞生長因子受體/細胞表面分化抗原抗體
Anti-phospho-c-kit/SCFR/CD117(pTyr936)  抗磷酸化原癌基因c-kit抗體
Anti-CD133 antigen  造血干細胞抗原CD133抗體
Anti-CD137/TNFRSF9   CD137抗體
Anti-CD138/Syndecan-1  多配體蛋白聚糖1抗體
Anti-CD146/MCAM  黑色素瘤細胞粘附分子CD146抗體
Anti-CD141(Thrombomodulin)  凝血調節蛋白抗體


智慧城市網 設計制作,未經允許翻錄必究 .? ? ? Copyright(C)?2021 http://www.cmr6829.com,All rights reserved.

以上信息由企業自行提供,信息內容的真實性、準確性和合法性由相關企業負責,智慧城市網對此不承擔任何保證責任。 溫馨提示:為規避購買風險,建議您在購買產品前務必確認供應商資質及產品質量。

會員登錄

×

請輸入賬號

請輸入密碼

=

請輸驗證碼

收藏該商鋪

登錄 后再收藏

提示

您的留言已提交成功!我們將在第一時間回復您~